Ocular and Vision Problems in Patients After Fontan Operation
1 other identifier
observational
65
1 country
1
Brief Summary
The purposes of this study are to identify indicators of vision problems and ocular abnormalities in patients with a Fontan circulation through a standardized questionnaire and to correlate the intraocular pressure measured with the Icare tonometer with central venous pressure measured with the VENUS 2000 CVP non-invasive system to determine whether intraocular pressure can be used as a surrogate measure of increased central venous pressure in patients with a Fontan circulation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2016
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 13, 2016
CompletedFirst Submitted
Initial submission to the registry
April 26, 2017
CompletedFirst Posted
Study publicly available on registry
May 31, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2022
CompletedMay 4, 2022
May 1, 2022
6.2 years
April 26, 2017
May 3, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Reported ocular medical history in Fontans
Number of participants with Fontan physiology that have undergone a Fontan operation that have reported any changes in ocular and vision abnormalities by using a standardized survey.
The final 3 months will be used for data analysis and the presentation/manuscript preparation.
Eligibility Criteria
The study will be conducted solely in the the Adult Congenital Heart Clinic at Stanford, and patients with congenital heart disease (CHD) will be recruited for the study.
You may qualify if:
- Patients (male and female) 18 and older with Fontan circulation
You may not qualify if:
- Patients under 18.
- Patients with any prior ocular trauma or surgery.
- Patients unwilling to consent to study.
- Patients who are unable to speak and read English.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Stanford Hospital Adult Congenital Heart Clinic
Palo Alto, California, 94304, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Susan Fernandes, LPD, PA-C
Stanford University
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor, Pediatrics - Cardiology Clinical Professor, Medicine - Cardiovascular Medicine
Study Record Dates
First Submitted
April 26, 2017
First Posted
May 31, 2017
Study Start
February 13, 2016
Primary Completion
May 1, 2022
Study Completion
May 1, 2022
Last Updated
May 4, 2022
Record last verified: 2022-05
Data Sharing
- IPD Sharing
- Will not share